The Concentrations of Markers of Bone Turnover in Normal Pregnancy and Preeclampsia

REFERENCES

• Namgung R, Tsang RC. Bone in the pregnant mother and newborn at birth. Clin Chim Acta 2003; 333(1):1–11.
   PubMed Web of Science ®Google Scholar
• Ulrich U, Miller PB, Eyre DR, Chesnut CH, Schlebusch H, Soules MR. Bone remodeling and bone mineral density during pregnancy. Arch Gynecol Obstet 2003; 268(4):309–316
   PubMedGoogle Scholar
• Sanchez-Ramos L, Sandroni S, Andres FL, Kaunitz AM. Calcium excretion in preeclampsia. Obstet Gynecol 1991; 77:510–514.
   PubMed Web of Science ®Google Scholar
• Sanchez-Ramos L, Jones DC, Cullen MT. Urinary calcium as an early marker of preeclampsia. Obstet Gynecol 1991; 77:685–690.
   PubMed Web of Science ®Google Scholar
• Graves SW, Wood RJ, Brown EM, Seely EW. Calcium and calciotropic hormones in transient hypertension of pregnancy versus pre-eclampsia. Hypertens Pregnancy 1994; 13:87–95.
   Web of Science ®Google Scholar
• Belizan JM, Villar J, Gonzales L, Campodonico L, Bergel E. Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med 1991; 325:1399–1404.
   PubMed Web of Science ®Google Scholar
• Brown MA. The physiology of pre-eclampsia. Clin Exp Pharmacol Physiol 1995; 22:781–791.
   PubMed Web of Science ®Google Scholar
• Taufield PA, Ales KL, Resnick LM, Druzin ML, Gertner JM, Laragh JH. Hypocalciuria in preeclampsia. N Engl J Med 1987; 316:715–718.
   PubMed Web of Science ®Google Scholar
• Frenkel Y, Barkai G, Mashiach S, Dolev E, Zimlichman R, Weiss M. Hypocalciuria of preeclampsia is independent of parathyroid hormone level. Obstet Gynecol 1991; 77:689–691.
   PubMed Web of Science ®Google Scholar
• Wang W, Xu S, Zan Z. The relation of parathyroid function to pregnancy-induced hypertension. Chin Med J 1995; 108:576–578.
   PubMed Web of Science ®Google Scholar
• Lalau JD, Jans I, el Esper N, Bouillon R, Fournier A. Calcium metabolism, plasma parathyroid hormone, and calcitriol in transient hypertension of pregnancy. Am J Hypertens 1993; 6:522–527.
   PubMed Web of Science ®Google Scholar
• Li LM. Calcium metabolism in normal pregnancy and pregnancy induced hypertension. Chung Hua Fu Chan Ko Tsa Chih 1993; 28:389–391.
   Google Scholar
• Frlich A, Rudnicki M., Storm T, Rasmussen N, Hegedüs L. Impaired 1,25-dihydroxyvitamin D production in pregnancy-induced hypertension. Eur J Obstet Gynecol Reprod Biol 1992; 47:25–29.
   PubMed Web of Science ®Google Scholar
• Siddiqui JA, Rana IA. Mineral and parathyroid hormone inter-relationships in normal pregnancy and pregnancy-induced hypertension. J Pak Med Assoc 1993; 43:92–95.
   PubMedGoogle Scholar
• Gao S, Liu G, Li L. Observation and analysis on metabolism of serum calcium and phosphorus in patients with pregnancy-induced hypertension. Chung Hua Liu Hsing Ping Hsueh Tsa Chih 1998; 9:350–352.
   Google Scholar
• Leibbrandt A, Penninger JM. RANK/RANKL: Regulators of immune responses and bone physiology. Ann N Y Acad Sci 2008; 1143:123–150.
   PubMed Web of Science ®Google Scholar
• Hofbauer LC, Heufelder AE. Role of receptor activator of nuclear factor-Kappa B ligand and osteoprotegrin in bone cell biology. J Mol Med 2001; 79:243–253.
   PubMed Web of Science ®Google Scholar
• Theill LE, Bovie WJ, Penninger JM. RANK-L and RANK: T cells, bone loss and mammalian evolution. Annu Rev Immunol 2002; 20:795–823.
   PubMed Web of Science ®Google Scholar
• Jones DH, Kong YY, Penninger JM. Role of RANKL and RANK in bone loss and arthritis. Ann Rheum Dis 2002; 61:32–39.
   PubMed Web of Science ®Google Scholar
• Naylor KE, Rogers A, Fraser RB, Hall V, Eastell R, Blumsohn A. Serum osteoprotegrin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation. J Clin Endocrin Metabol 2003; 88(11):5361–5365.
   PubMed Web of Science ®Google Scholar
• Uemura H, Yasui T, Kiyokawa M, Serum osteoprotegrin/osteoclastogenesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers. J Endocrinol 2002; 174(2):353–359.
   PubMed Web of Science ®Google Scholar
• Power MJ, Fottrell PF. Osteocalcin: Diagnostic methods and clinical applications. Crit Rev Clin Lab Sci 1991; 28(4):287–335.
   PubMed Web of Science ®Google Scholar
• Mori M. Beta-crosslaps. Nippon Rinsho 2004; 62(12):247–249.
   PubMedGoogle Scholar
• National High Blood Pressure Education Program Working Group report on high blood pressure in pregnancy. Am J Obstet Gynecol 1991; 165(1):236–237.
   Google Scholar
• Black AJ, Topping J, Farquharson R, Fraser WD. Bone metabolism in pregnancy: A review. Contemp Rev Obstet Gynaecol 1996; 8:192–196.
   Google Scholar
• Shahtaheri SM, Aaron JE, Johnson DR, Purdie DW. Changes in trabecular bone architecture in women during pregnancy. Br J Obstet Gynaecol 1999; 106:432–438.
   PubMedGoogle Scholar
• Purdie DW, Aaron JE, Selby PL. Bone histology and mineral homeostasis in human pregnancy. Br J Obstet Gynaecol 1998; 95:849–854.
   Google Scholar
• Black AJ, Topping J, Durham B, Farquharson RG, Fraser WD. A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy. J Bone Miner Res 2000; 15:557–563.
   PubMed Web of Science ®Google Scholar
• Yasumizu T, Kato J. Concentrations of serum markers of type I collagen synthesis and degradation and serum osteocalcin in maternal and umbilical circulation. Endocr J 1996; 43:191–195.
   PubMed Web of Science ®Google Scholar
• Ainy E, Ghazi AA, Azizi F. Changes in calcium, 25(OH) vitamin D3 and other biochemical factors during pregnancy. J Endocrinol Invest 2006; 29(4):303–307.
   PubMed Web of Science ®Google Scholar
• Hong JS, Santolaya-Forgas J, Romero R, Maternal plasma osteoprotegrin concentrations in normal pregnancy. Am J Obstet Gynecol 2005; 193(3):1011–1015.
   PubMed Web of Science ®Google Scholar
• Briana DD, Boutsikou M, Baka S, Hassiakos D, Gourgiotis D, Malamitsi-Puchner A. Circulating osteoprotegrin and sRANKL concentrations in the perinatal period at term. The impact of intrauterine growth restriction. Neonatology 2009; 96(2):2009.
   Web of Science ®Google Scholar
• Briana DD, Gourgiotis D, Boutsikou M, Perinatal bone in term pregnancies: The influence of intrauterine growth restriction. Bone 2008; 42(2):307–313.
   PubMed Web of Science ®Google Scholar
• Seely EW, Wood RJ, Brown EM, Graves SW. Lower serum ionized calcium and abnormal calciotropic hormone levels in preeclampsia. J Clin Endocrinol Metab 1992; 74:1436–1440.
   PubMed Web of Science ®Google Scholar
• Shaarawy M, Zaki S, Ramzi AM, Salem ME, El-Minavi AM. Feto-maternal bone remodeling in normal pregnancy and pre-eclampsia. J Soc Gynecol Invest 2005; 12(5):343–348.
   PubMedGoogle Scholar
• Kumptepe Y, Aksoy H, Ingec M. Bone turnover in preeclamptic and normotensive pregnancy. Int J Obstet Gynecol 2005; 88(3):323–324.
   PubMed Web of Science ®Google Scholar
• Anim-Nyame N, Sooranna SR, Jones J, Alaghband-Zadeh J, Steer PJ, Johnson MR. Biochemical markers of maternal bone turnover are elevated in pre-eclampsia. BJOG 108 (3):258–262.
   PubMed Web of Science ®Google Scholar
• Anim-Nyame N, Sooranna SR, Jones J, Alaghband-Zadeh J, Steer PJ, Johnson MR. A longitudinal study of biochemical markers of bone turnover during normal pregnancy and pregnancies complicated by pre-eclampsia. BJOG 2002; 109(6):708–713.
   PubMed Web of Science ®Google Scholar
• Sowers M, Scholl T, Grewal J, Chen X, Jannausch M. IGF-I, osteocalcin and bone change in pregnant normotensive and pre-eclamptic women. J Clin Endocrin Metabol 2001; 86 (11):5898–5903.
   PubMed Web of Science ®Google Scholar